Biodesix Inc. (BDSX)
0.68
-0.03 (-4.60%)
At close: Mar 28, 2025, 2:53 PM
Biodesix Income Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Revenue | 71.32M | 49.09M | 38.21M | 54.51M | 45.56M | 24.55M | 20.43M |
| Cost of Revenue | n/a | 13.01M | 14.15M | 30.52M | 22M | 6.07M | 4.41M |
| Gross Profit | 71.32M | 36.08M | 24.06M | 23.99M | 23.56M | 18.48M | 16.03M |
| Operating Income | -34.5M | -41.34M | -50.51M | -39.32M | -22.12M | -22.63M | -23.46M |
| Interest Income | n/a | n/a | 8.07M | 4.51M | 18K | 55K | 24K |
| Pretax Income | -42.93M | -52.15M | -65.45M | -43.16M | -31.35M | -30.73M | -26.17M |
| Net Income | -42.93M | -52.15M | -80.39M | -44.48M | -36.47M | -31.36M | -26.17M |
| Selling & General & Admin | 80.45M | 67.39M | 61.46M | 50.52M | 34.86M | 30.64M | 25.9M |
| Research & Development | 9.56M | 9.99M | 13.1M | 12.79M | 10.82M | 10.47M | 8.19M |
| Other Expenses | 15.81M | 44K | 109K | -9K | 422K | -2.38M | -1.24M |
| Operating Expenses | 105.82M | 77.42M | 74.56M | 63.31M | 45.67M | 41.1M | 34.09M |
| Interest Expense | 8.26M | 9.54M | 8.07M | 4.51M | 7.6M | 3.01M | 2.92M |
| Selling & Marketing Expenses | n/a | n/a | 61.46M | 50.52M | 34.86M | 30.64M | 25.9M |
| Cost & Expenses | 105.82M | 90.43M | 88.72M | 93.82M | 67.67M | 47.18M | 38.49M |
| Income Tax | n/a | n/a | 14.94M | 1.32M | 5.12M | 629K | 211K |
| Shares Outstanding (Basic) | 129.67M | 82.11M | 42.1M | 27.36M | 26.56M | 25.49M | 26.54M |
| Shares Outstanding (Diluted) | 129.67M | 82.11M | 42.1M | 27.36M | 26.56M | 25.49M | 26.54M |
| EPS (Basic) | -0.33 | -0.64 | -1.91 | -1.63 | -1.37 | -1.23 | -0.99 |
| EPS (Diluted) | -0.33 | -0.64 | -1.91 | -1.63 | -1.37 | -1.23 | -0.99 |
| EBITDA | -34.5M | -37.1M | -53.78M | -35.47M | -20.84M | -24.93M | -21.51M |
| Depreciation & Amortization | n/a | 5.51M | 3.6M | 3.18M | 2.9M | 2.79M | 1.74M |